Welcome to chemicalbook!
+1 (818) 612-2111
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >IDH-305
IDH-305
  • IDH-305

IDH-305 NEW

Price $52 $128 $178
Package 1mg 5mg 10mg
Min. Order:
Supply Ability: 10g
Update Time: 2025-10-26

Product Details

Product Name: IDH-305 CAS No.: 1628805-46-8
Purity: 99.13% Supply Ability: 10g
Release date: 2025/10/26

Product Introduction

Bioactivity

NameIDH-305
DescriptionIDH-305 is an orally available, mutation-selective, and brain-penetrant IDH1 inhibitor targeting the IDH1 (R132) mutation. It is 200-fold more selective for mutant IDH1 isoforms than wild type, with IC50s of 27 nM, 28 nM, and 6.14 nM for IDH1R132H, IDH1R132C, and IDH1WT, respectively.
In vitroIDH-305 suppresses HCT116-IDH1R132H /- cells (IC50 of 24 nM)[1].
In vivoP.o. administration of 30-300 mg/kg IDH-305 twice daily for 21 days suppresses 2-HG production and 2-HG-dependent tumor growth of an IDH1 mutant PDX melanoma model [1].
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility InformationDMSO : 100 mg/mL (203.89 mM), Sonication is recommended.
KeywordsIsocitrate Dehydrogenase (IDH) | Inhibitor | inhibit | IDH-305 | IDH305 | IDH1-WT | IDH1WT | IDH1-R132H | IDH1R132H | IDH1-R132C | IDH1R132C | IDH 305
Inhibitors RelatedDisulfiram | 1-Methoxy-4-propylbenzene | Methotrexate | Mycophenolate Mofetil | 18β-Glycyrrhetinic acid | Ribavirin | Methotrexate disodium | 2-Methylaminoethanol | Benzyl alcohol | 2-Bromoacetamide | Isomalt | Sodium Oxamate
Related Compound LibrariesBioactive Compound Library | ReFRAME Related Library | Hematonosis Compound Library | Anti-Cancer Metabolism Compound Library | Anti-Cancer Clinical Compound Library | Drug Repurposing Compound Library | Inhibitor Library | Metabolism Compound Library | Bioactive Compounds Library Max | Anti-Liver Cancer Compound Library | Anti-Cancer Active Compound Library | Anti-Cancer Drug Library

Company Profile Introduction

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers. TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$1230.00/25mg
VIP2Y
TargetMol Chemicals Inc.
2025-10-27
$812.00/100μg
VIP4Y
TargetMol Chemicals Inc.
2025-08-29
$50.00/1kg
Anhui Ruihan Technology Co., Ltd
2023-09-08

TargetMol Chemicals Inc.

6YR United StatesUnited States
  • Since: 2011-01-07
  • Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY